Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 8, 2015, Pages 339.e17-339.e23

  Sharma, Pranav ^a   Zargar Shoshtari, Kamran ^a   Caracciolo, Jamie T ^a   Fishman, Mayer ^a   Poch, Michael A ^a   Pow Sang, Julio ^a   Sexton, Wade J ^a   Spiess, Philippe E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cytoreductive nephrectomy; Metastatic; Renal cell carcinoma; Sarcopenia; Survival

Indexed keywords

HEMOGLOBIN; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOALBUMINEMIA; KIDNEY METASTASIS; LENGTH OF STAY; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE; SYSTEMIC THERAPY; THREE DIMENSIONAL IMAGING; ADVERSE EFFECTS; CARCINOMA, RENAL CELL; KIDNEY NEOPLASMS; METASTASIS; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEPHRECTOMY; PROGNOSIS; SARCOPENIA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84937524930     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.01.011     Document Type: Article

References (34)

1. Heng D.Y., Xie W., Regan M.M., et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol 2009, 27:5794.
2. Margulis V., Shariat S.F., Rapoport Y., et al. Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol 2013, 63:947.
3. Ohno Y., Nakashima J., Ohori M., et al. Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status. Int J Clin Oncol 2014, 19:139.
4. Sakai I., Miyake H., Hinata N., et al. Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy. Int J Clin Oncol 2014, 19:674.
5. Blum D., Stene G.B., Solheim T.S., et al. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model-a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol 2014, 25:1635.
6. Alves A., Panis Y., Mathieu P., et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg 2005, 140:278.
7. Peng P., Hyder O., Firoozmand A., et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012, 16:1478.
8. Psutka S.P., Carrasco A., Schmit G.D., et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 2014, 120(18):2910-2918.
9. Fearon K., Strasser F., Anker S.D., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011, 12:489.
10. Mourtzakis M., Prado C.M., Lieffers J.R., et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008, 33:997.
11. Prado C.M., Lieffers J.R., McCargar L.J., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629.
12. Martin L., Birdsell L., Macdonald N., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013, 31:1539.
13. Bock J. Serum protein concentration and relative albumin percentage in normal individuals. Acta Physiol Scand 1949, 18:231.
14. Bigot P., Lebdai S., Ravaud A., et al. The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies. World J Urol 2013, 31:1383.
15. Heng D.Y., Wells J.C., Rini B.I., et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium. Eur Urol 2014, 66:704.
16. Capitanio U., Abdollah F., Matloob R., et al. Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy. Int J Urol 2013, 20:572.
17. Conti S.L., Thomas I.C., Hagedorn J.C., et al. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Int J Cancer 2014, 134:2245.
18. Stroup S.P., Raheem O.A., Palazzi K.L., et al. Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study. Urology 2013, 81:805.
19. Trinh Q.D., Sukumar S., Schmitges J., et al. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy. Ann Surg Oncol 2013, 20:2096.
20. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010, 39:412.
21. Antoun S., Baracos V.E., Birdsell L., et al. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 2010, 21:1594.
22. Cushen S.J., Power D.G., Teo M.Y., et al. Body composition by computed tomography as a predictor of toxicity in patients with renal cell carcinoma treated with sunitinib. Am J Clin Oncol 2014, [Epub ahead of print].
23. Kamat A.M., Shock R.P., Naya Y., et al. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 2004, 63:46.
24. Psutka SP, Boorjian SA, Moynagh MR, et al. Mortality after radical cystectomy: the impact of obesity versus adiposity after adjusting for skeletal muscle wasting. J Urol 2014, [Epub ahead of print].
25. Harimoto N., Shirabe K., Yamashita Y.I., et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013, 100:1523.
26. Tan B.H., Birdsell L.A., Martin L., et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009, 15:6973.
27. Corcoran A.T., Kaffenberger S.D., Clark P.E., et al. Hypoalbuminemia is associated with mortality in patients undergoing cytoreductive nephrectomy. BJU Int 2014, [Epub ahead of print].
28. Gregg J.R., Cookson M.S., Phillips S., et al. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol 2011, 185:90.
29. Doumas B.T., Peters T. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1997, 258:3.
30. Afolabi P.R., Jahoor F., Gibson N.R., et al. Response of hepatic proteins to the lowering of habitual dietary protein to the recommended safe level of intake. Am J Physiol Endocrinol Metab 2004, 287:E327.
31. Lo H.C., Lin C.H., Tsai L.J. Effects of hypercaloric feeding on nutrition status and carbon dioxide production in patients with long-term mechanical ventilation. JPEN J Parenter Enteral Nutr 2005, 29:380.
32. Seres D.S. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutr Clin Pract 2005, 20:308.
33. Waters D.L., Baumgartner R.N., Garry P.J., et al. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010, 5:259.
34. Robinson S., Cooper C., Aihie Sayer A. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. J Aging Res 2012, 2012:510801.